AI assistant
Sending…
Esperion Therapeutics, Inc. — Director's Dealing 2021
May 28, 2021
32771_dirs_2021-05-28_a8c6977a-e6aa-4d23-a4b6-157ff9e0a4db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Esperion Therapeutics, Inc. (ESPR)
CIK: 0001434868
Period of Report: 2021-05-27
Reporting Person: MCGOVERN MARK E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-27 | Common Stock | A | 12376 | — | Acquired | 28449 | Direct |
Footnotes
F1: The shares vest in full on the earlier of (i) May 27, 2022 and (ii) the Issuer's next annual meeting of stockholders following May 27, 2021.
More from Esperion Therapeutics, Inc.
Merger & Acquisition
2026
Jun 8
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 1
Interim / Quarterly Report
2026
May 8
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 17
M&A Activity
2026
Mar 3